Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2007 | $0.16 | 2007-12-19 | 2007-12-21 |
| December 31, 2007 | $0.03 | 2007-12-19 | 2007-12-21 |
| December 31, 2007 | $0.01 | 2007-12-19 | 2007-12-21 |
Dividends Summary
- Consistent Payer: has rewarded shareholders with 3 dividend payments over the past 0 years.
- Total Returned Value: Investors who held ACB shares during this period received a total of $0.20 per share in dividend income.
- Latest Payout: The most recent dividend of $0.16/share was paid 6774 days ago, on December 31, 2007.
- Dividend Growth: Since 2007, the dividend payout has grown by 1684.7%, from $0.01 to $0.16.
Company News
Canopy Growth announced it will restate financial results for two years due to a technical accounting error involving share-settled warrants that should have been classified as liabilities rather than equity. The company states the restatement won't impact revenue, operating income, cash flows, or key performance metrics. However, the stock remai...
Aurora Cannabis has lost 96% of its value since 2021 and faces significant challenges despite recent U.S. cannabis reclassification from Schedule I to Schedule III. The company has no meaningful U.S. market presence after shutting down its Reliva CBD operations in 2023, and with weak revenue growth and consistent losses, it is unlikely to capital...
The recreational cannabis market is projected to grow from $2.24 billion in 2025 to $3.32 billion by 2030, with a CAGR of 7.8-8.2%. Growth is driven by increasing legalization, public acceptance, demand for high-THC products, and innovation in premium edibles, beverages, and vape formats. Key players are launching innovative products and pursuing...
President Trump's executive order to reschedule cannabis to Schedule 3 could eliminate Section 280E of the Internal Revenue Code, allowing U.S. cannabis operators to deduct business expenses for the first time. This represents the most significant federal cannabis policy shift in over 50 years. However, challenges remain including inability to li...
President Trump's executive order rescheduling cannabis from Schedule 1 to Schedule 3 has improved the regulatory landscape for the cannabis industry, offering easier banking access and business expense deductions. However, analyst Prosper Junior Bakiny argues that Canopy Growth and Aurora Cannabis lack attractive investment prospects despite thi...
